A Lactobacillus delbrueckii subsp. bulgaricus fermented skimmed milk powder has limited effects on gastrointestinal health in healthy individuals with mild-to-moderate gastrointestinal symptoms: results from a randomised controlled trial
Gut Microbiome · 2026 · 7
DOI: 10.1017/gmb.2026.10031 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Gut Microbiome, online erschienen am 31.07.2026. Verfasst von Martina Rooney und 13 weiteren Autor:innen. Beteiligte Einrichtung: University College Dublin, Food for Health Ireland, Ireland. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fermented dairy foods offer potential to improve gastrointestinal symptoms due to their functional characteristics (e.g., presence of potentially health-promoting microorganisms, and/or bioactives), which may improve quality of life (QoL). This study examined the effect of a Lactobacillus delbrueckii subsp. bulgaricus fermented skimmed milk powder (FSMP) on gastrointestinal health in healthy individuals with mild-to-moderate gastrointestinal symptoms. Subjects received 20 g/day of either the FSMP, skimmed milk powder (SMP), or maltodextrin for 8 weeks. QoL, faecal calprotectin, gut transit time, gas evacuations, stool consistency, dietary intake, and anthropometry were all assessed. Eighty-four participants (62% female, 34.9 ± 5.9 years) completed the trial. SMP improved anxiety ( P = 0.015), discomfort ( P = 0.002), and global ( P = 0.010) domain scores vs. maltodextrin. Similarly, SMP improved discomfort ( P = 0.007) and global ( P = 0.023) domain score relative to FSM P . No other differences between groups post-intervention were observed ( P > 0.05). Sub-analyses indicated those with more severe symptoms at baseline had more normal stool consistency ( P = 0.016) and fewer gas evacuations ( P = 0.008) in response to FSM P relative to maltodextrin. Overall, this exploratory analysis found an L. delbrueckii subsp. bulgaricus FSMP had limited effects on gastrointestinal health in this cohort.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University College Dublin, Food for Health Ireland, Ireland.
- Institute of Food and Health, University College Dublin, Ireland.
- School of Food and Nutritional Sciences, University College Cork College of Science Engineering and Food Science, Ireland.
- Teagasc Food Research Centre Moorepark, Ireland.
- Department of Food Biosciences, Teagasc Food Research Centre Moorepark, Ireland.
- University College Cork APC Microbiome Institute, Ireland.
ORCID-Profile: Martina Rooney, Clíona Ní Chonnacháin
Zitieren
APA
Rooney, M., Ní Chonnacháin, C., Finnerty, B., Bennett, G., Gregory, É., Carey, C., Mechoud, M., Panthi, R. R., Mathur, H., Murphy, E. G., Beresford, T., Cotter, P. D., Lucey, A., & Feeney, E. L. (2026). A Lactobacillus delbrueckii subsp. bulgaricus fermented skimmed milk powder has limited effects on gastrointestinal health in healthy individuals with mild-to-moderate gastrointestinal symptoms: results from a randomised controlled trial. Gut Microbiome, 7. https://doi.org/10.1017/gmb.2026.10031
Vancouver
Rooney M, Ní Chonnacháin C, Finnerty B, Bennett G, Gregory É, Carey C, et al. A Lactobacillus delbrueckii subsp. bulgaricus fermented skimmed milk powder has limited effects on gastrointestinal health in healthy individuals with mild-to-moderate gastrointestinal symptoms: results from a randomised controlled trial. Gut Microbiome. 2026;7. doi:10.1017/gmb.2026.10031
BibTeX
@article{Rooney2026,
author = {Rooney, Martina and Ní Chonnacháin, Clíona and Finnerty, Bernadette and Bennett, Grace and Gregory, Éimear and Carey, Conor and Mechoud, Monica and Panthi, Ram Raj and Mathur, Harsh and Murphy, Eoin G and Beresford, Tom and Cotter, Paul D and Lucey, Alice and Feeney, Emma L},
title = {A Lactobacillus delbrueckii subsp. bulgaricus fermented skimmed milk powder has limited effects on gastrointestinal health in healthy individuals with mild-to-moderate gastrointestinal symptoms: results from a randomised controlled trial},
journal = {Gut Microbiome},
year = {2026},
volume = {7},
doi = {10.1017/gmb.2026.10031}
}
EUVIMED